Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-1-29
pubmed:abstractText
Increased signaling by transforming growth factor beta (TGFbeta) has been implicated in systemic sclerosis (SSc; scleroderma), a complex disorder of connective tissues characterized by excessive accumulation of collagen and other extracellular matrix components in systemic organs. To directly assess the effect of sustained TGFbeta signaling in SSc, we established a novel mouse model in which the TGFbeta signaling pathway is activated in fibroblasts postnatally.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/4-hydroxytamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Activin Receptors, Type I, http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1, http://linkedlifedata.com/resource/pubmed/chemical/Protein C Inhibitor, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Transforming Growth..., http://linkedlifedata.com/resource/pubmed/chemical/Smad2 Protein, http://linkedlifedata.com/resource/pubmed/chemical/Smad2 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/Smad3 Protein, http://linkedlifedata.com/resource/pubmed/chemical/Smad3 protein, mouse, http://linkedlifedata.com/resource/pubmed/chemical/TGF-beta type I receptor, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0004-3591
pubmed:author
pubmed:issnType
Print
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
334-44
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:17195237-Activin Receptors, Type I, pubmed-meshheading:17195237-Animals, pubmed-meshheading:17195237-Cell Differentiation, pubmed-meshheading:17195237-Cells, Cultured, pubmed-meshheading:17195237-Disease Models, Animal, pubmed-meshheading:17195237-Female, pubmed-meshheading:17195237-Fibroblasts, pubmed-meshheading:17195237-Gene Targeting, pubmed-meshheading:17195237-Male, pubmed-meshheading:17195237-Mice, pubmed-meshheading:17195237-Mice, Inbred C57BL, pubmed-meshheading:17195237-Mice, Transgenic, pubmed-meshheading:17195237-Phosphorylation, pubmed-meshheading:17195237-Plasminogen Activator Inhibitor 1, pubmed-meshheading:17195237-Protein C Inhibitor, pubmed-meshheading:17195237-Protein-Serine-Threonine Kinases, pubmed-meshheading:17195237-Receptors, Transforming Growth Factor beta, pubmed-meshheading:17195237-Scleroderma, Systemic, pubmed-meshheading:17195237-Signal Transduction, pubmed-meshheading:17195237-Skin, pubmed-meshheading:17195237-Smad2 Protein, pubmed-meshheading:17195237-Smad3 Protein, pubmed-meshheading:17195237-Tamoxifen, pubmed-meshheading:17195237-Transforming Growth Factor beta
pubmed:year
2007
pubmed:articleTitle
Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma.
pubmed:affiliation
University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural